Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 17%
Hold 50%
Sell 17%
Strong Sell 0%

Bulls say

Omega Healthcare Invts is well-positioned for growth in the healthcare real estate sector, with a diverse portfolio that includes both skilled nursing facilities and seniors housing assets. Recent tenant concerns have abated, and management is actively deploying capital to drive accretive acquisitions. The stock is currently trading at a premium to NAV and historical FFO multiples, and our analysis forecasts an optimistic outlook with a potential price target of $56 over the next 12 months.

Bears say

Omega Healthcare Invts is facing several headwinds including the general economic and regulatory trends in the SNF reimbursement environment, potential labor shortages, and volatile access to capital. Additionally, the sale of the CommuniCare portfolio may initially dilute earnings, and the company's reliance on third-party operators can be risky in terms of occupancy and profitability. Furthermore, the regulatory environment for healthcare facilities is unpredictable, and Omega faces tenant-specific risks such as potential legal issues with the PACS Group. We are lowering our 2027 FFO estimate and do not expect significant growth in the near term, leading us to maintain a Neutral rating on the stock.

OHI has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 17% recommend Buy, 50% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Hold based on their latest research and market trends.

According to 12 analysts, OHI has a Hold consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $49.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $49.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.